- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.38 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 19 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x WA7: (1S,2S,3R,4S,5S)-1-(hydroxymethyl)-5-[(4-{[2-nitro-4-(triazan-1-yl)phenyl]amino}butyl)amino]cyclohexane-1,2,3,4-tetrol(Non-covalent)
WA7.2: 15 residues within 4Å:- Chain A: F.306, W.422, D.450, I.451, I.487, W.524, W.561, D.563, F.570, R.623, W.636, D.639, F.672, H.697, H.699
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:W.524, A:F.672
- Hydrogen bonds: A:D.450, A:D.563, A:R.623, A:D.639, A:D.639
- Water bridges: A:R.695, A:R.695
- pi-Stacking: A:W.524, A:F.570
- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.4: 3 residues within 4Å:- Chain A: S.955, A.957, S.958
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.958
PEG.8: 6 residues within 4Å:- Chain A: G.828, T.860, A.861, Q.862, S.887, F.888
No protein-ligand interaction detected (PLIP)PEG.12: 7 residues within 4Å:- Chain A: N.441, F.723, R.838, R.839
- Chain B: S.107, R.108, D.111
6 PLIP interactions:3 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:R.838, A:R.839, A:R.839, B:S.107, B:R.108, B:D.111
PEG.26: 4 residues within 4Å:- Chain B: N.89, G.90, S.91, L.105
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:P.88
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.23: 3 residues within 4Å:- Chain A: R.425, R.466
- Ligands: SO4.24
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.466
SO4.24: 3 residues within 4Å:- Chain A: N.423, R.425
- Ligands: SO4.23
3 PLIP interactions:3 interactions with chain A- Water bridges: A:R.421, A:N.423
- Salt bridges: A:R.425
- 2 x CA: CALCIUM ION(Non-covalent)
CA.28: 6 residues within 4Å:- Chain B: Q.67, D.70, Y.72, D.74, D.80, E.81
6 PLIP interactions:6 interactions with chain B- Metal complexes: B:Q.67, B:D.70, B:Y.72, B:D.74, B:D.80, B:E.81
CA.29: 6 residues within 4Å:- Chain B: R.108, D.111, V.113, D.115, D.121, E.122
6 PLIP interactions:6 interactions with chain B- Metal complexes: B:R.108, B:D.111, B:V.113, B:D.115, B:D.121, B:E.122
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karade, S.S. et al., N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum alpha-Glucosidases I and II with Antiviral Activity. J.Med.Chem. (2021)
- Release Date
- 2021-10-06
- Peptides
- Isoform 2 of Neutral alpha-glucosidase AB: A
Glucosidase 2 subunit beta: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.38 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 19 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x WA7: (1S,2S,3R,4S,5S)-1-(hydroxymethyl)-5-[(4-{[2-nitro-4-(triazan-1-yl)phenyl]amino}butyl)amino]cyclohexane-1,2,3,4-tetrol(Non-covalent)
- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karade, S.S. et al., N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum alpha-Glucosidases I and II with Antiviral Activity. J.Med.Chem. (2021)
- Release Date
- 2021-10-06
- Peptides
- Isoform 2 of Neutral alpha-glucosidase AB: A
Glucosidase 2 subunit beta: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D